patent infringement
Ravgen NIPT Patents Withstand Illumina Challenge
The US Patent Trial and Appeal Board delivered a pair of rulings stating that Illumina failed to show Ravgen's innovations should be considered unpatentable.
Natera Files Second Patent Infringement Suit Against NeoGenomics Subsidiary Inivata
The suit was filed the same day Natera received a new patent covering its patient-specific residual cancer testing and monitoring methods.
Ravgen's NIPT Patents Found Valid in Administrative Challenge
The small Maryland-based firm has launched patent lawsuits and negotiated licensing terms over technology used in market-leading noninvasive prenatal tests.
The firm alleges its competitors infringe its patents describing processes for finding chromosomal abnormalities in fetal cell-free DNA.
Quest Diagnostics, Ravgen Settle Patent Infringement Suit
Ravgen had accused Quest of patent infringement through the QNatal Advanced prenatal screening assay, and the firms had been scheduled to start a jury trial Tuesday.